ABOUT US
With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery.
We supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. Visit cytiva.com to learn more.
VIDEOS
WEBINARS
BROCHURES AND DATASHEETS
- Allegro MVP Single-Use System
- An IoT Solution For A Reliable, Real-Time Informed Diagnosis
- A Flexible Service Model With Rapid Response And Access To Knowledge
- Online Service Solutions For Optimal Performance Of Your Instruments
- Single‑Use Filtration System For Pilot‑ And Small‑Scale Manufacturing
- Datasheet: AxiChrom™ Columns
- A Ready-To-Use, Single-Use Liquid Chromatography System
- ÄKTA process™ Automated Liquid Chromatography System
- Mechanistic Chromatography Modeling To Accelerate Process Development
- Selecting An Affinity Chromatography Resin For Your Antibody
APPLICATION NOTES
- Extractables In Single-Use Systems Used In ADC Manufacturing
- Adapting Single-Use Chromatography To Manufacturing Scale
- Developing A Large-Scale Tangential Flow Filtration Process
- Bulk Filling Of Drug Substance | Accurate Aliquoting
- Sterilizing Grade Filter Performance With Biologic Drugs
- Developing A HIC Polishing Step For The Removal Of mAb Aggregates
- Alkaline Stability Of Modern Protein A Chromatography Resins
- Protein L Affinity Resin Is Ready To Move To Manufacturing
- AAV Full/Empty Capsid Separation Using Mechanistic Modeling
- Recombinant Protein Purification Optimization With HIC
CONTACT INFORMATION
Cytiva
100 Results Way
Marlborough, MA 08855-1327
UNITED STATES
Phone: 800-526-3593
FEATURED ARTICLES
-
Gain insight into the current landscape of filling and late-stage manufacturing from a survey of 78 professionals from top companies in the industry.
-
One way to address risk related to product quality is by implementing a Question-based Review approach. Read on to learn about this approach and its advantages.
-
Given the numerous stakeholders involved throughout a product's lifecycle and the limited direct control companies have, how can biopharma organizations effectively measure and manage Scope 3 emissions?
-
What actions are biopharma leaders worldwide taking to enhance sustainability? What challenges are they encountering? And how can the broader industry learn from the companies paving the way?
-
Explore some of the biggest obstacles companies are encountering and what is already being done to move the industry closer to significant sustainability progress and environmental achievements.
-
Explore key insights into how sustainability efforts are influencing business outcomes from a survey that collected data from 800 pharma and biopharma executives across 18 countries.
-
What steps is the biopharma industry taking to enhance sustainability? What challenges does biopharma encounter? And how can the entire industry draw lessons from the companies setting the standard?
-
Learn about the changes introduced in the latest revision to EU GMP Annex 1, and gain insight into the components that should be part of a PUPSIT risk assessment.
-
Learn about a program that has been developed to facilitate risk mitigation before process-specific filter validation is performed.
-
Clarification using depth filtration is standard in monoclonal antibody (mAb) manufacturing. Here, we showcase the scalability of Stax™ mAx depth filters, demonstrating their effectiveness.